In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (282)
Video
Reducing the Unexpected and Unnecessary Costs of Musculoskeletal Condition Care
May 18, 2022
Musculoskeletal (MSK) injuries or disorders affect nearly half of U.S. adults1 and are one of the top health categories of plan sponsor spend at $420B.
This topic was the focus of a breakout session at Outcomes+ 2022.
Article
Nurses Improve Health Outcomes
May 13, 2022
Whether nurses have direct interaction with patients or work in non-traditional roles, their knowledge and expertise can improve health outcomes for patients.
Article
Underserved Communities at Greater Risk for Non-adherence to Diabetes Medication
May 12, 2022
Evernorth Geographic Social Determinants Index (EGSDI) identifies opportunities for proactive patient and community engagement for individuals diagnosed with type 2 diabetes.
Video
What Is Drug Trend and How to Manage it
April 21, 2022
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access.
This topic was the focus of a breakout session at Outcomes+ 2022.
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
April 20, 2022
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.
This topic was the focus of a breakout session at Outcomes+ 2022.
Report
Use of Smoking Cessation Medications Significantly Decline Amid Pandemic
March 31, 2022
Data suggests employers and health plans need a renewed focus on tobacco use interventions.
